Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Axogen, Inc.

AXGN · Nasdaq · CIK 0000805928 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

25 Form 4 transaction lines observed in the same window
11 sales · 14 option, withholding, award, gift or other lines

Last qualifying purchase2024-08-08 · TYNDALL JOSEPH A. · $26.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Wendell Amy McBrideDirector
○▼○○▼
Weiler Kathy JohnsonDirector
○▼○▼
JOHNSON JOHNDirector
○▼○
TYNDALL JOSEPH A.Director
○▼
Hartley Lindsey MarieCFO
○▼
Began Marc AEVP & General Counsel
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-08-08 · TYNDALL JOSEPH A..

Recent Form 4 activity

0Purchases
42Sales
58Other Form 4 lines
45SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING11 sale line(s) · context only
OTHER14 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-12.0%
3M
-4.3%
6M
+10.9%
12M
+126.0%

Volatility & liquidity

Volatility
57.4%
Beta
—
Avg daily value
USD 44.9M

Valuation

Market cap
USD 2.0B
P/E
—

Fundamentals

Profit margin
-7.0%
ROE
-12.2%
Industry
Medical Devices

Market data

Price data up to: 2026-10-12 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-27 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
4,697,283
Previous report
4,055,417
Avg daily volume
1,127,117
Days to cover
4.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-08-08TYNDALL JOSEPH A.Purchase (P)Common Stock2,525USD 10.50USD 26,512SEC filing ↗
2023-09-06Wendell Amy McBridePurchase (P)Common Stock10,000USD 6.22USD 62,200SEC filing ↗
2023-08-23Burke William P. Mr.Purchase (P)Common Stock10,000USD 6.56USD 65,600SEC filing ↗
2023-08-16NEELS GUIDO JPurchase (P)Common Stock10,000USD 6.11USD 61,100SEC filing ↗

Form 4 evidence

100 transaction lines in the latest 365-day window; 554 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02TYNDALL JOSEPH A.Sale (S)Common Stock3,500USD 49.70USD 173,950SEC filing ↗
2026-08-11Wendell Amy McBrideSale (S)Common Stock13,353USD 48.42USD 646,552SEC filing ↗
2026-08-11Wendell Amy McBrideOption exercise / conversion (M)Common Stock13,353USD 14.85USD 198,292SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02TYNDALL JOSEPH A.Sale (S)Common Stock3,500USD 49.70USD 173,950SEC filing ↗
2026-08-11Wendell Amy McBrideSale (S)Common Stock13,353USD 48.42USD 646,552SEC filing ↗
2026-08-11Wendell Amy McBrideOption exercise / conversion (M)Common Stock13,353USD 14.85USD 198,292SEC filing ↗
2026-08-10Began Marc ASale (S)Common Stock67,500USD 47.35USD 3,196,125SEC filing ↗
2026-08-10Began Marc AOption exercise / conversion (M)Common Stock67,500USD 8.16USD 550,800SEC filing ↗
2026-08-07Weiler Kathy JohnsonSale (S)Common Stock14,150USD 45.30USD 640,995SEC filing ↗
2026-06-19Wendell Amy McBrideOption exercise / conversion (M)Common Stock14,150USD 0.00USD 0SEC filing ↗
2026-06-19Weiler Kathy JohnsonOption exercise / conversion (M)Common Stock14,150USD 0.00USD 0SEC filing ↗
2026-06-19TYNDALL JOSEPH A.Option exercise / conversion (M)Common Stock14,150USD 0.00USD 0SEC filing ↗
2026-06-19THOMAS PAULOption exercise / conversion (M)Common Stock18,867USD 0.00USD 0SEC filing ↗
2026-06-19Levine Alan MOption exercise / conversion (M)Common Stock14,150USD 0.00USD 0SEC filing ↗
2026-06-19JOHNSON JOHNOption exercise / conversion (M)Common Stock14,150USD 0.00USD 0SEC filing ↗
2026-06-19Burke William P. Mr.Option exercise / conversion (M)Common Stock14,150USD 0.00USD 0SEC filing ↗
2026-05-08Wendell Amy McBrideSale (S)Common Stock1,647USD 42.60USD 70,162SEC filing ↗
2026-05-08Wendell Amy McBrideOption exercise / conversion (M)Common Stock1,647USD 14.85USD 24,458SEC filing ↗
2026-05-07Weiler Kathy JohnsonSale (S)Common Stock16,344USD 44.09USD 720,607SEC filing ↗
2026-05-07Weiler Kathy JohnsonOption exercise / conversion (M)Common Stock16,344USD 6.95USD 113,591SEC filing ↗
2026-05-07Quackenbush DorisSale (S)Common Stock3,878USD 43.51USD 168,732SEC filing ↗
2026-05-07Kemp JensSale (S)Common Stock4,000USD 43.44USD 173,760SEC filing ↗
2026-05-07JOHNSON JOHNSale (S)Common Stock11,050USD 43.26USD 478,023SEC filing ↗
2026-05-07JOHNSON JOHNOption exercise / conversion (M)Common Stock11,050USD 7.04USD 77,792SEC filing ↗
2026-05-07Hartley Lindsey MarieSale (S)Common Stock1,051USD 43.67USD 45,897SEC filing ↗
2026-05-07Hartley Lindsey MarieOption exercise / conversion (M)Common Stock5,463USD 8.24USD 45,004SEC filing ↗
2026-03-16Hartley Lindsey MarieOption exercise / conversion (M)Common Stock9,000USD 0.00USD 0SEC filing ↗
2026-03-16Hartley Lindsey MarieTax withholding (F)Common Stock3,542USD 32.84USD 116,319SEC filing ↗
2026-03-16DeVinney Erick WayneSale (S)Common Stock5,221USD 32.84USD 171,458SEC filing ↗
2026-03-16DeVinney Erick WayneOption exercise / conversion (M)Common Stock17,938USD 0.00USD 0SEC filing ↗
2026-03-16DeVinney Erick WayneTax withholding (F)Common Stock2,870USD 32.84USD 94,251SEC filing ↗
2026-03-01Kemp JensTax withholding (F)Common Stock2,952USD 30.65USD 90,479SEC filing ↗
2026-03-01DeVinney Erick WayneTax withholding (F)Common Stock11,276USD 30.65USD 345,609SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAXGN
CIK0000805928
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3845 Electromedical & Electrotherapeutic Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history554 transaction lines from 2020-01-01 to 2026-09-02
4 P purchase lines · 125 S sale lines · 425 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.